HEADER OXIDOREDUCTASE 30-OCT-09 3KHM TITLE CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TITLE 2 TRYPANOSOMA CRUZI IN COMPLEX WITH INHIBITOR FLUCONAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROL 14 ALPHA-DEMETHYLASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 24-481; COMPND 5 EC: 1.14.13.70; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA CRUZI; SOURCE 3 ORGANISM_TAXID: 5693; SOURCE 4 GENE: CYP51; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HMS174; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PCW KEYWDS STEROL 14-ALPHA DEMETHYLASE, CYP51, CYTOCHROME P450, HEME, KEYWDS 2 OXIDOREDUCTASE, MONOOXYGENASE, ENDOPLASMIC RETICULUM, TRANSMEMBRANE KEYWDS 3 PROTEIN, STEROL BIOSYNTHESIS, LIPIDS, MEMBRANE, IRON, HEME THIOLATE KEYWDS 4 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.I.LEPESHEVA,T.Y.HARGROVE,S.ANDERSON,Z.WAWRZAK,M.R.WATERMAN REVDAT 6 06-SEP-23 3KHM 1 REMARK REVDAT 5 13-OCT-21 3KHM 1 REMARK SEQADV REVDAT 4 13-JUL-11 3KHM 1 VERSN REVDAT 3 25-AUG-10 3KHM 1 JRNL REVDAT 2 23-JUN-10 3KHM 1 JRNL REVDAT 1 10-NOV-09 3KHM 0 JRNL AUTH G.I.LEPESHEVA,T.Y.HARGROVE,S.ANDERSON,Y.KLESHCHENKO, JRNL AUTH 2 V.FURTAK,Z.WAWRZAK,F.VILLALTA,M.R.WATERMAN JRNL TITL STRUCTURAL INSIGHTS INTO INHIBITION OF STEROL JRNL TITL 2 14{ALPHA}-DEMETHYLASE IN THE HUMAN PATHOGEN TRYPANOSOMA JRNL TITL 3 CRUZI. JRNL REF J.BIOL.CHEM. V. 285 25582 2010 JRNL REFN ISSN 0021-9258 JRNL PMID 20530488 JRNL DOI 10.1074/JBC.M110.133215 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.400 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 11141 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 593 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.92 REMARK 3 REFLECTION IN BIN (WORKING SET) : 664 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.13 REMARK 3 BIN R VALUE (WORKING SET) : 0.3510 REMARK 3 BIN FREE R VALUE SET COUNT : 39 REMARK 3 BIN FREE R VALUE : 0.3550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3517 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 48.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.470 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.396 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 46.601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3670 ; 0.003 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4969 ; 0.365 ; 2.017 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 438 ; 4.740 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 161 ;28.392 ;23.292 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 655 ;13.941 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;12.307 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 536 ; 0.025 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2758 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2204 ; 0.722 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3569 ; 1.393 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1466 ; 2.069 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1400 ; 3.394 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 24 A 501 REMARK 3 ORIGIN FOR THE GROUP (A): 9.7320 -24.8820 18.2560 REMARK 3 T TENSOR REMARK 3 T11: 0.5813 T22: 0.2838 REMARK 3 T33: 0.2711 T12: 0.1016 REMARK 3 T13: -0.0074 T23: 0.0258 REMARK 3 L TENSOR REMARK 3 L11: 3.6229 L22: 4.2198 REMARK 3 L33: 4.5247 L12: 0.3833 REMARK 3 L13: 0.0484 L23: 0.9267 REMARK 3 S TENSOR REMARK 3 S11: -0.2877 S12: 0.3685 S13: -0.1357 REMARK 3 S21: -0.5004 S22: 0.0349 S23: 0.0359 REMARK 3 S31: -0.3608 S32: -0.5977 S33: 0.2529 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3KHM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-09. REMARK 100 THE DEPOSITION ID IS D_1000056003. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97928 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12181 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.400 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.50200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3K1O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, POTASSIUM FORMATE, SODIUM REMARK 280 CHLORIDE, PH 7.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.08267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 148.16533 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 148.16533 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 74.08267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 212 REMARK 465 VAL A 213 REMARK 465 PHE A 214 REMARK 465 MET A 215 REMARK 465 PRO A 216 REMARK 465 TRP A 217 REMARK 465 GLU A 250 REMARK 465 GLU A 251 REMARK 465 ALA A 252 REMARK 465 SER A 253 REMARK 465 LYS A 254 REMARK 465 ASP A 255 REMARK 465 ASN A 256 REMARK 465 ASN A 257 REMARK 465 THR A 258 REMARK 465 PRO A 480 REMARK 465 SER A 481 REMARK 465 HIS A 482 REMARK 465 HIS A 483 REMARK 465 HIS A 484 REMARK 465 HIS A 485 REMARK 465 HIS A 486 REMARK 465 HIS A 487 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 25 -86.47 -117.88 REMARK 500 ALA A 115 -131.08 56.83 REMARK 500 TRP A 158 72.31 -118.21 REMARK 500 SER A 206 -3.83 -54.99 REMARK 500 ILE A 209 78.20 -118.82 REMARK 500 HIS A 388 1.80 -68.29 REMARK 500 HIS A 458 -60.80 -142.90 REMARK 500 ASN A 467 17.09 -69.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 422 SG REMARK 620 2 HEM A 500 NA 96.4 REMARK 620 3 HEM A 500 NB 80.3 89.0 REMARK 620 4 HEM A 500 NC 86.1 177.1 90.1 REMARK 620 5 HEM A 500 ND 102.6 90.9 177.1 89.8 REMARK 620 6 TPF A 501 N5 159.9 92.9 82.1 84.3 94.9 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TPF A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3K1O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM REMARK 900 TRYPANOSOMA CRUZI IN COMPLEX WITH POSACONAZOLE DBREF 3KHM A 24 481 UNP Q5I4E1 Q5I4E1_TRYCR 24 481 SEQADV 3KHM LYS A 24 UNP Q5I4E1 PHE 24 ENGINEERED MUTATION SEQADV 3KHM THR A 25 UNP Q5I4E1 ASN 25 ENGINEERED MUTATION SEQADV 3KHM SER A 26 UNP Q5I4E1 THR 26 ENGINEERED MUTATION SEQADV 3KHM GLY A 27 UNP Q5I4E1 THR 27 ENGINEERED MUTATION SEQADV 3KHM LYS A 28 UNP Q5I4E1 ARG 28 ENGINEERED MUTATION SEQADV 3KHM GLY A 29 UNP Q5I4E1 PRO 29 ENGINEERED MUTATION SEQADV 3KHM LYS A 30 UNP Q5I4E1 THR 30 ENGINEERED MUTATION SEQADV 3KHM LEU A 31 UNP Q5I4E1 ASP 31 ENGINEERED MUTATION SEQADV 3KHM HIS A 482 UNP Q5I4E1 EXPRESSION TAG SEQADV 3KHM HIS A 483 UNP Q5I4E1 EXPRESSION TAG SEQADV 3KHM HIS A 484 UNP Q5I4E1 EXPRESSION TAG SEQADV 3KHM HIS A 485 UNP Q5I4E1 EXPRESSION TAG SEQADV 3KHM HIS A 486 UNP Q5I4E1 EXPRESSION TAG SEQADV 3KHM HIS A 487 UNP Q5I4E1 EXPRESSION TAG SEQRES 1 A 464 LYS THR SER GLY LYS GLY LYS LEU PRO PRO VAL TYR PRO SEQRES 2 A 464 VAL THR VAL PRO PHE LEU GLY HIS ILE VAL GLN PHE GLY SEQRES 3 A 464 LYS ASN PRO LEU GLU PHE MET GLN ARG CYS LYS ARG ASP SEQRES 4 A 464 LEU LYS SER GLY VAL PHE THR ILE SER ILE GLY GLY GLN SEQRES 5 A 464 ARG VAL THR ILE VAL GLY ASP PRO HIS GLU HIS SER ARG SEQRES 6 A 464 PHE PHE SER PRO ARG ASN GLU ILE LEU SER PRO ARG GLU SEQRES 7 A 464 VAL TYR THR ILE MET THR PRO VAL PHE GLY GLU GLY VAL SEQRES 8 A 464 ALA TYR ALA ALA PRO TYR PRO ARG MET ARG GLU GLN LEU SEQRES 9 A 464 ASN PHE LEU ALA GLU GLU LEU THR ILE ALA LYS PHE GLN SEQRES 10 A 464 ASN PHE VAL PRO ALA ILE GLN HIS GLU VAL ARG LYS PHE SEQRES 11 A 464 MET ALA GLU ASN TRP LYS GLU ASP GLU GLY VAL ILE ASN SEQRES 12 A 464 LEU LEU GLU ASP CYS GLY ALA MET ILE ILE ASN THR ALA SEQRES 13 A 464 CYS GLN CYS LEU PHE GLY GLU ASP LEU ARG LYS ARG LEU SEQRES 14 A 464 ASN ALA ARG HIS PHE ALA GLN LEU LEU SER LYS MET GLU SEQRES 15 A 464 SER SER LEU ILE PRO ALA ALA VAL PHE MET PRO TRP LEU SEQRES 16 A 464 LEU ARG LEU PRO LEU PRO GLN SER ALA ARG CYS ARG GLU SEQRES 17 A 464 ALA ARG ALA GLU LEU GLN LYS ILE LEU GLY GLU ILE ILE SEQRES 18 A 464 VAL ALA ARG GLU LYS GLU GLU ALA SER LYS ASP ASN ASN SEQRES 19 A 464 THR SER ASP LEU LEU GLY GLY LEU LEU LYS ALA VAL TYR SEQRES 20 A 464 ARG ASP GLY THR ARG MET SER LEU HIS GLU VAL CYS GLY SEQRES 21 A 464 MET ILE VAL ALA ALA MET PHE ALA GLY GLN HIS THR SER SEQRES 22 A 464 THR ILE THR THR SER TRP SER MET LEU HIS LEU MET HIS SEQRES 23 A 464 PRO LYS ASN LYS LYS TRP LEU ASP LYS LEU HIS LYS GLU SEQRES 24 A 464 ILE ASP GLU PHE PRO ALA GLN LEU ASN TYR ASP ASN VAL SEQRES 25 A 464 MET ASP GLU MET PRO PHE ALA GLU ARG CYS VAL ARG GLU SEQRES 26 A 464 SER ILE ARG ARG ASP PRO PRO LEU LEU MET VAL MET ARG SEQRES 27 A 464 MET VAL LYS ALA GLU VAL LYS VAL GLY SER TYR VAL VAL SEQRES 28 A 464 PRO LYS GLY ASP ILE ILE ALA CYS SER PRO LEU LEU SER SEQRES 29 A 464 HIS HIS ASP GLU GLU ALA PHE PRO ASN PRO ARG LEU TRP SEQRES 30 A 464 ASP PRO GLU ARG ASP GLU LYS VAL ASP GLY ALA PHE ILE SEQRES 31 A 464 GLY PHE GLY ALA GLY VAL HIS LYS CYS ILE GLY GLN LYS SEQRES 32 A 464 PHE ALA LEU LEU GLN VAL LYS THR ILE LEU ALA THR ALA SEQRES 33 A 464 PHE ARG GLU TYR ASP PHE GLN LEU LEU ARG ASP GLU VAL SEQRES 34 A 464 PRO ASP PRO ASP TYR HIS THR MET VAL VAL GLY PRO THR SEQRES 35 A 464 LEU ASN GLN CYS LEU VAL LYS TYR THR ARG LYS LYS LYS SEQRES 36 A 464 LEU PRO SER HIS HIS HIS HIS HIS HIS HET HEM A 500 43 HET TPF A 501 22 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM TPF 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL) HETNAM 2 TPF PROPAN-2-OL HETSYN HEM HEME HETSYN TPF FLUCONAZOLE; ALPHA-(2,4-DIFLUOROPHENYL)-ALPHA-(1H-1,2, HETSYN 2 TPF 4-TRIAZOLE-1-YLMETHYL)-1H-1,2,4-TRIAZOLE-1-ETHANOL; HETSYN 3 TPF ELAZOR; TRIFLUCAN; BIOZOLENE FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 TPF C13 H12 F2 N6 O HELIX 1 1 HIS A 44 ASN A 51 1 8 HELIX 2 2 ASN A 51 LEU A 63 1 13 HELIX 3 3 ASP A 82 HIS A 84 5 3 HELIX 4 4 GLU A 85 SER A 91 1 7 HELIX 5 5 TYR A 103 ILE A 105 5 3 HELIX 6 6 MET A 106 GLY A 111 1 6 HELIX 7 7 VAL A 114 ALA A 118 5 5 HELIX 8 8 PRO A 119 LEU A 134 1 16 HELIX 9 9 THR A 135 PHE A 139 5 5 HELIX 10 10 ASN A 141 TRP A 158 1 18 HELIX 11 11 LEU A 167 PHE A 184 1 18 HELIX 12 12 GLY A 185 LEU A 192 1 8 HELIX 13 13 ASN A 193 MET A 204 1 12 HELIX 14 14 SER A 226 GLU A 248 1 23 HELIX 15 15 ASP A 260 LYS A 267 1 8 HELIX 16 16 SER A 277 HIS A 309 1 33 HELIX 17 17 ASN A 312 ASP A 324 1 13 HELIX 18 18 ASN A 331 MET A 339 1 9 HELIX 19 19 MET A 339 ASP A 353 1 15 HELIX 20 20 SER A 383 HIS A 388 1 6 HELIX 21 21 ALA A 417 LYS A 421 5 5 HELIX 22 22 GLY A 424 GLU A 442 1 19 HELIX 23 23 LEU A 466 GLN A 468 5 3 SHEET 1 A 5 VAL A 67 ILE A 70 0 SHEET 2 A 5 VAL A 77 VAL A 80 -1 O ILE A 79 N PHE A 68 SHEET 3 A 5 ILE A 379 CYS A 382 1 O ALA A 381 N THR A 78 SHEET 4 A 5 VAL A 359 VAL A 363 -1 N ARG A 361 O ILE A 380 SHEET 5 A 5 LEU A 97 SER A 98 -1 N SER A 98 O MET A 362 SHEET 1 B 3 GLU A 162 ASN A 166 0 SHEET 2 B 3 LEU A 470 ARG A 475 -1 O VAL A 471 N ILE A 165 SHEET 3 B 3 TYR A 443 LEU A 447 -1 N ASP A 444 O THR A 474 SHEET 1 C 2 VAL A 367 VAL A 369 0 SHEET 2 C 2 TYR A 372 VAL A 374 -1 O TYR A 372 N VAL A 369 SHEET 1 D 2 PRO A 455 ASP A 456 0 SHEET 2 D 2 GLY A 463 PRO A 464 -1 O GLY A 463 N ASP A 456 LINK SG CYS A 422 FE HEM A 500 1555 1555 2.21 LINK FE HEM A 500 N5 TPF A 501 1555 1555 2.16 CISPEP 1 THR A 25 SER A 26 0 -6.27 CISPEP 2 SER A 26 GLY A 27 0 -4.78 CISPEP 3 PRO A 210 ALA A 211 0 -0.88 SITE 1 AC1 22 ARG A 124 LEU A 127 LEU A 134 ALA A 288 SITE 2 AC1 22 ALA A 291 GLY A 292 THR A 295 THR A 299 SITE 3 AC1 22 PRO A 355 LEU A 356 VAL A 359 ARG A 361 SITE 4 AC1 22 GLY A 414 PHE A 415 GLY A 416 VAL A 419 SITE 5 AC1 22 HIS A 420 LYS A 421 CYS A 422 ILE A 423 SITE 6 AC1 22 GLY A 424 TPF A 501 SITE 1 AC2 6 TYR A 116 PHE A 290 ALA A 291 THR A 295 SITE 2 AC2 6 LEU A 356 HEM A 500 CRYST1 62.591 62.591 222.248 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015977 0.009224 0.000000 0.00000 SCALE2 0.000000 0.018448 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004499 0.00000